You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venetoclax

Showing 326 - 350 of 485
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Mantle-Cell Trial in Italy (Venetoclax)

Active, not recruiting
  • Lymphoma, Mantle-Cell
  • Venetoclax
  • Alessandria, Italy
  • +34 more
Aug 1, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +13 more
  • Polatuzumab Vedotin
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Aug 23, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

Completed
  • Chronic Lymphocytic Leukemia
    • Calgary, Alberta, Canada
    • +12 more
    Jul 7, 2022

    Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • Venetoclax
    • AMG 176
    • Duarte, California
    • +16 more
    Dec 3, 2021

    Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Zanubrutinib)

    Recruiting
    • Chronic Lymphoid Leukemia
    • Aachen, Germany
    • +20 more
    Oct 5, 2021

    Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Boston, Massachusetts
    • +3 more
    Jun 30, 2021

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

    Active, not recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 25, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Venetoclax
    • La Plata, Buenos Aires, Argentina
    • +32 more
    Feb 10, 2022

    Real World Outcomes Using Novel Agents for AML in the UK

    Not yet recruiting
    • Acute Myeloid Leukemia
    • London, United Kingdom
      Guy's and St Thomas' NHS Foundation Trust
    Mar 28, 2022

    Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
      • Moscow, Moskva, Russian Federation
      • +9 more
      Jan 27, 2022

      Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

      Completed
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Birmingham, Alabama
      • +14 more
      Aug 23, 2021

      Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)

      Active, not recruiting
      • Relapsed Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Oct 7, 2022

      Acute Myeloid Leukemia (AML) Trial in United States (Venetoclax, Gilteritinib)

      Completed
      • Acute Myeloid Leukemia (AML)
      • Los Angeles, California
      • +10 more
      Sep 7, 2021

      Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • The combination of HHT, venetoclax, AZA, G-CSF
      • (no location specified)
      Mar 28, 2021

      Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, AML, Adult Trial in Orange (Pitavastatin, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Mar 25, 2021

      Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jun 30, 2022

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

      Recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 2, 2022

      MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Leukemia, Myelomonocytic, Chronic
      • (no location specified)
      Aug 5, 2022

      B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

      Recruiting
      • B Acute Lymphoblastic Leukemia
      • Ph-Like Acute Lymphoblastic Leukemia
      • Duarte, California
        City of Hope Medical Center
      Jul 26, 2022

      Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Trial in Australia, United States (Navitoclax, Chemotherapy,

      Completed
      • Acute Lymphoblastic Leukemia (ALL)
      • Lymphoblastic Lymphoma
      • Duarte, California
      • +14 more
      Oct 7, 2021

      Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)

      Recruiting
      • Acute Leukemia, in Relapse
      • Acute Leukemia Refractory
      • CVA regimen bridging to HSCT
      • Suzhou, Jiangsu, China
        The First Affliated Hospital of Soochow University
      Jan 4, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Birmingham, Alabama
      • +49 more
      Jan 20, 2023

      Adult Acute Myeloid Leukemia Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion,

      Recruiting
      • Adult Acute Myeloid Leukemia
      • microtransplantation, HLA-mismatched donor peripheral stem cell infusion
      • +2 more
      • Beijing, Beijing, China
        The fifth medical center of PLA General Hospital
      Feb 21, 2022

      MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)

      Active, not recruiting
      • Myelodysplastic Syndromes (MDS)
      • Tucson, Arizona
      • +36 more
      Aug 1, 2022